Fatigue in Ankylosing Spondylitis: Causes, Consequences and Self-Management

被引:29
作者
Farren, Wendy [1 ]
Goodacre, Lynne [2 ]
Stigant, Mark [3 ]
机构
[1] North Cumbria Univ Hosp NHS Trust Carlisle, Whitehaven, England
[2] Univ Lancaster, Lancaster, England
[3] Univ Cumbria, Carlisle, England
关键词
Ankylosing spondylitis; fatigue; causes; consequences; management;
D O I
10.1002/msc.1029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To explore the perceived causes, consequences and management of fatigue in ankylosing spondylitis (AS). Methods. In this single-cohort qualitative study, ten participants completed a seven-day diary and participated in a semi-structured interview exploring possible causes, consequences and self-management of fatigue. Interviews were recorded, transcribed and analysed using 'framework' analysis. Ethical approval was obtained. Results. Three themes emerged: patterns and causes, consequences and management of fatigue. While patients' descriptions of fatigue were similar, the patterns and perceived causes of fatigue varied between individuals. Fatigue impacted on social life, relationships and work. Two approaches to fatigue management were observed: help and support from others and self-management, with four participants having sought medical help for fatigue. Conclusions. The study suggested that fatigue has a negative impact on quality of life in people with AS. Future practice should include a comprehensive fatigue assessment and the development of treatment programmes directed at enhancing self-management techniques. Copyright (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 50 条
[1]   A qualitative investigation of fatigue among healthy working adults [J].
Aaronson, LS ;
Pallikkathayil, L ;
Crighton, F .
WESTERN JOURNAL OF NURSING RESEARCH, 2003, 25 (04) :419-433
[2]  
Barlow JH, 2001, ARTHRIT RHEUM-ARTHR, V45, P424, DOI 10.1002/1529-0131(200110)45:5<424::AID-ART361>3.0.CO
[3]  
2-7
[4]   Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients [J].
Boonen, A ;
Chorus, A ;
Miedema, H ;
van der Heijde, D ;
van der Tempel, H ;
van der Linden, S .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (04) :353-358
[5]  
Bradt J, 2001, ARTHRITIS RHEUMATISM, V43, P1346
[6]   Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Golder, W ;
Gromica-Ihle, E ;
Kellner, H ;
Krause, A ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Thriene, W ;
Sieper, J .
LANCET, 2002, 359 (9313) :1187-1193
[7]  
Brophy S, 2002, J RHEUMATOL, V29, P954
[8]   Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis [J].
Calin, A ;
Dijkmans, BAC ;
Emery, P ;
Hakala, M ;
Kalden, J ;
Leirisalo-Repo, M ;
Mola, EM ;
Salvarani, C ;
Sanmartí, R ;
Sany, J ;
Sibilia, J ;
Sieper, J ;
van der Linden, S ;
Veys, E ;
Appel, AM ;
Fatenejad, S .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) :1594-1600
[9]  
CALIN A, 1993, J RHEUMATOL, V20, P991
[10]   Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? [J].
Calin, A ;
Nakache, JP ;
Gueguen, A ;
Zeidler, H ;
Mielants, H ;
Dougados, M .
RHEUMATOLOGY, 1999, 38 (09) :878-882